H. G. Pars Pharmaceutical Labo

Basic Information

763 Concord Avenue
Cambridge, MA, 02138

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. H.

    Amount: $50,000.00

    H. G. PARS PHARMACEUTICAL LABORATORIES' LONG-TERM GOAL IS TO DEVELOP AND MARKET AN ORALLY ACTIVE ANTIHYPERTENSIVE DRUG FROM ITS SERIES OF SULFUR AND NITROGEN CANNABINOID ANALOGS. HYPOTENSIVE CANNABINO ...

    SBIR Phase I 1985 Department of Health and Human Services
  2. THE MODIFICATION OF-LACTAM ANTIBIOTICS CONTINUES TO BE A PROMISING MEANS FOR THE IMPROVEMENT OF THIS VERY IMPORTANT CLASS OF ANTIMICROBIALS.

    Amount: $50,000.00

    THE MODIFICATION OF -LACTAM ANTIBIOTICS CONTINUES TO BE A PROMISING MEANS FOR THE IMPROVEMENT OF THIS VERY IMPORTANT CLASS OF ANTIMICROBIALS. THE VARIED USEFUL ATTRIBUTES OF THE NEW OXACEPHALOSPORIN M ...

    SBIR Phase I 1985 Department of Health and Human Services
  3. CURRENT BACTERIOCIDAL AND FUNGICIDAL AGENTS ARE UNSATISFACTORY FOR USE ON SENSITIVE SOFT TISSUE OR MUCOUS MEMBRANE.

    Amount: $50,000.00

    CURRENT BACTERIOCIDAL AND FUNGICIDAL AGENTS ARE UNSATISFACTORY FOR USE ON SENSITIVE SOFT TISSUE OR MUCOUS MEMBRANE. THERE IS NO KNOWN CHEMICAL AGENT WHICH POSSESSES BROAD-RANGE BACTERIOCIDAL AND FUNGI ...

    SBIR Phase I 1985 Department of Health and Human Services
  4. AN EFFECTIVE ORAL MALE ANTIFERTILITY AGENT, WHICH IS BOTH NONTOXIC AND REVERSIBLE, IS NOT CURRENTLY AVAILABLE.

    Amount: $50,000.00

    AN EFFECTIVE ORAL MALE ANTIFERTILITY AGENT, WHICH IS BOTH NONTOXIC AND REVERSIBLE, IS NOT CURRENTLY AVAILABLE. GOSSYPOL, THE MOST PROMISING NONSTEROIDAL MALE ANTIFERTILITY LEAD, HAS AN UNACCEPTABLY NA ...

    SBIR Phase I 1985 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government